Success Story: 2-Month NIW Victory Without RFE for Cancer Biology Postdoctoral Fellow from Sri Lanka
Client’s Testimonial:
“We had an amazing experience working with Chen Immigration on our I-140 application. We were introduced to your firm through a friend whose I-140 was approved earlier this year. Your team's professional guidance, supportive approach, and expert service made the entire process smooth and reassuring.”
On January 26th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: Sri Lanka
Country of Residence at the Time of Filing: Canada
Approval Notice Date: January 26th, 2026
Processing Time: 2 months and 9 days
Case Summary:
"The fact that [The Client]’s broader research was selected for this highly competitive support underscores the recognized value of [The Client]’s work across cancer biology and highlights [The Client]’s impact on both scientific progress and clinical practice."
The statement above is taken from one recommendation letter submitted as part of the EB-2 NIW (National Interest Waiver) petition for a Ph.D. in medical sciences holder from Sri Lanka.Client Background and Proposed Endeavor
As an expert in the field of cancer biology, the proposed endeavor is to continue research on elucidating molecular mechanisms, identifying novel therapeutics, and advancing personalized medicine through the use of cell-based assays and advanced biotechnological approaches, combined with computer-aided drug design and validation on preclinical models. With extensive training in pharmacology, genetics, and translational cancer research, this scientist is actively advancing groundbreaking research in rare and advanced metastatic cancers with direct applications to patient survival and therapeutic innovation.
National Significance of the Research
We emphasized that this research is of significant importance and has far-reaching implications for the United States. The work directly addresses the urgent need for improved treatment of rare and advanced metastatic cancers, strengthening public health initiatives nationwide.
This research reveals critical molecular mechanisms linking dietary factors to cancer progression and identifies novel therapeutic targets for under-researched cancers. Additionally, the findings align with the Cancer Moonshot initiative and advance progress in critical and emerging biotechnology areas.
Impressive Credentials and Achievements
To further strengthen the case, we highlighted exceptional credentials:
- Publications: An impressive portfolio of 5 peer-reviewed journal articles (1 of them first-authored), 1 paper under review (first-authored), and 26 abstracts (17 of them first-authored).
- Citations: The work has been cited 100 times, demonstrating influence within the scientific community and the practical application of the findings by other researchers advancing the field of cancer biology.
- Peer Review Service: The client has been invited to conduct a peer review for a leading oncology journal and has completed at least 1 review to date.
- Competitive Funding: The research has been supported by major funding sources, including the Neuroendocrine Tumor Research Foundation, affirming the significance and national importance of the work.
Considering the exceptional strength of the accomplishments and the national importance of the proposed endeavor, we are delighted to share that this NIW petition was approved in over 2 months without RFE. The innovative work in cancer biology and translational research, combined with demonstrated expertise in molecular mechanisms and personalized medicine approaches, positions this researcher to make transformative contributions to U.S. cancer treatment and patient survival outcomes for years to come.